American Shared Hospital Services Schedules First Quarter 2026 Financial Results Conference Call

American Shared Hospital Services (NYSE American: AMS) will release its Q1 2026 financial results and hold a conference call on May 14, providing investors insight into its latest performance and strategic direction.

NY Metrowire Staff
Healthcare
American Shared Hospital Services Schedules First Quarter 2026 Financial Results Conference Call

American Shared Hospital Services (NYSE American: AMS), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, announced today that it will release its first quarter 2026 financial results before the market opens on May 14, 2026. The company will hold a conference call at 12:00 PM ET the same day to discuss the results.

Investors and analysts can participate in the call by dialing 1-844-413-3972 for domestic callers or 1-412-317-5776 for international callers at least ten minutes before the start time. A simultaneous webcast will be available through the company's website at www.ashs.com or directly via this link.

A telephonic replay of the call will be available from May 14 through May 21, 2026, by dialing 1-855-669-9658 or 1-412-317-0088 and entering access code 6753554. The webcast will also be archived on the company's website.

American Shared Hospital Services provides turnkey solutions to cancer treatment centers, health systems, and cancer networks across North and South America. The company works closely with partners to develop and grow cancer service lines, offering integrated cancer care in local community settings. Under its health system partnerships, AMS shares capital investment and profitability based on respective ownership interests.

The conference call comes as the company continues to expand its Gamma Knife, proton therapy, and advanced radiation therapy businesses. These forward-looking statements involve risks and uncertainties, including economic conditions, compliance with debt covenants, variability of financial results, changes in CMS reimbursement rates, and risks associated with expanding into new markets. Further details are available in the company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025.

Blockchain Registration

QR Code for Blockchain Registration